Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis

Jin Wang, Neera Malik, Meng Yin, Thomas Christopher Smyrk, Albert J. Czaja, Richard Lorne Ehman, Sudhakar K Venkatesh

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

AIM To assess the value of magnetic resonance elastography (MRE) in detecting advanced fibrosis/cirrhosis in autoimmune hepatitis (AIH). METHODS In this retrospective study, 36 patients (19 treated and 17 untreated) with histologically confirmed AIH and liver biopsy performed within 3 mo of MRE were identified at a tertiary care referral center. Liver stiffness (LS) with MRE was calculated by a radiologist, and inflammation grade and fibrosis stage in liver biopsy was assessed by a pathologist in a blinded fashion. Two radiologists evaluated morphological features of cirrhosis on conventional magnetic resonance imaging (MRI). Accuracy of MRE was compared to laboratory markers and MRI for detection of advanced fibrosis/cirrhosis. RESULTS Liver fibrosis stages of 0, 1, 2, 3 and 4 were present in 4, 6, 7, 6 and 13 patients respectively. There were no significant differences in distribution of fibrosis stage and inflammation grade between treated and untreated patient groups. LS with MRE demonstrated stronger correlation with liver fibrosis stage in comparison to laboratory markers for chronic liver disease (r = 0.88 vs -0.48-0.70). A trend of decreased mean LS in treated patients compared to untreated patients was observed (3.7 kPa vs 3.84 kPa) but was not statistically significant. MRE had an accuracy/ sensitivity/specificity/positive predictive value/negative predictive value of 0.97/90%/100%/100%/90% and 0.98/92.3%/96%/92.3%/96% for detection of advanced fibrosis and cirrhosis, respectively. The performance of MRE was significantly better than laboratory tests for detection of advanced fibrosis (0.97 vs 0.53-0.80, p < 0.01), and cirrhosis (0.98 vs 0.58-0.80, p < 0.01) and better than conventional MRI for diagnosis of cirrhosis (0.98 vs 0.78, p = 0.002). CONCLUSION MRE is a promising modality for detection of advanced fibrosis and cirrhosis in patients with AIH with superior diagnostic accuracy compared to laboratory assessment and MRI.

Original languageEnglish (US)
Pages (from-to)859-868
Number of pages10
JournalWorld Journal of Gastroenterology
Volume23
Issue number5
DOIs
StatePublished - Feb 7 2017

Fingerprint

Elasticity Imaging Techniques
Autoimmune Hepatitis
Fibrosis
Magnetic Resonance Imaging
Liver
Tertiary Care Centers
Liver Cirrhosis
Biomarkers
Inflammation
Biopsy

Keywords

  • Advanced fibrosis
  • Autoimmune hepatitis
  • Cirrhosis
  • Liver stiffness
  • Magnetic resonance elastography

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis. / Wang, Jin; Malik, Neera; Yin, Meng; Smyrk, Thomas Christopher; Czaja, Albert J.; Ehman, Richard Lorne; Venkatesh, Sudhakar K.

In: World Journal of Gastroenterology, Vol. 23, No. 5, 07.02.2017, p. 859-868.

Research output: Contribution to journalArticle

@article{ddcfd657dbd840a995bc02504a3acea7,
title = "Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis",
abstract = "AIM To assess the value of magnetic resonance elastography (MRE) in detecting advanced fibrosis/cirrhosis in autoimmune hepatitis (AIH). METHODS In this retrospective study, 36 patients (19 treated and 17 untreated) with histologically confirmed AIH and liver biopsy performed within 3 mo of MRE were identified at a tertiary care referral center. Liver stiffness (LS) with MRE was calculated by a radiologist, and inflammation grade and fibrosis stage in liver biopsy was assessed by a pathologist in a blinded fashion. Two radiologists evaluated morphological features of cirrhosis on conventional magnetic resonance imaging (MRI). Accuracy of MRE was compared to laboratory markers and MRI for detection of advanced fibrosis/cirrhosis. RESULTS Liver fibrosis stages of 0, 1, 2, 3 and 4 were present in 4, 6, 7, 6 and 13 patients respectively. There were no significant differences in distribution of fibrosis stage and inflammation grade between treated and untreated patient groups. LS with MRE demonstrated stronger correlation with liver fibrosis stage in comparison to laboratory markers for chronic liver disease (r = 0.88 vs -0.48-0.70). A trend of decreased mean LS in treated patients compared to untreated patients was observed (3.7 kPa vs 3.84 kPa) but was not statistically significant. MRE had an accuracy/ sensitivity/specificity/positive predictive value/negative predictive value of 0.97/90{\%}/100{\%}/100{\%}/90{\%} and 0.98/92.3{\%}/96{\%}/92.3{\%}/96{\%} for detection of advanced fibrosis and cirrhosis, respectively. The performance of MRE was significantly better than laboratory tests for detection of advanced fibrosis (0.97 vs 0.53-0.80, p < 0.01), and cirrhosis (0.98 vs 0.58-0.80, p < 0.01) and better than conventional MRI for diagnosis of cirrhosis (0.98 vs 0.78, p = 0.002). CONCLUSION MRE is a promising modality for detection of advanced fibrosis and cirrhosis in patients with AIH with superior diagnostic accuracy compared to laboratory assessment and MRI.",
keywords = "Advanced fibrosis, Autoimmune hepatitis, Cirrhosis, Liver stiffness, Magnetic resonance elastography",
author = "Jin Wang and Neera Malik and Meng Yin and Smyrk, {Thomas Christopher} and Czaja, {Albert J.} and Ehman, {Richard Lorne} and Venkatesh, {Sudhakar K}",
year = "2017",
month = "2",
day = "7",
doi = "10.3748/wjg.v23.i5.859",
language = "English (US)",
volume = "23",
pages = "859--868",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "5",

}

TY - JOUR

T1 - Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis

AU - Wang, Jin

AU - Malik, Neera

AU - Yin, Meng

AU - Smyrk, Thomas Christopher

AU - Czaja, Albert J.

AU - Ehman, Richard Lorne

AU - Venkatesh, Sudhakar K

PY - 2017/2/7

Y1 - 2017/2/7

N2 - AIM To assess the value of magnetic resonance elastography (MRE) in detecting advanced fibrosis/cirrhosis in autoimmune hepatitis (AIH). METHODS In this retrospective study, 36 patients (19 treated and 17 untreated) with histologically confirmed AIH and liver biopsy performed within 3 mo of MRE were identified at a tertiary care referral center. Liver stiffness (LS) with MRE was calculated by a radiologist, and inflammation grade and fibrosis stage in liver biopsy was assessed by a pathologist in a blinded fashion. Two radiologists evaluated morphological features of cirrhosis on conventional magnetic resonance imaging (MRI). Accuracy of MRE was compared to laboratory markers and MRI for detection of advanced fibrosis/cirrhosis. RESULTS Liver fibrosis stages of 0, 1, 2, 3 and 4 were present in 4, 6, 7, 6 and 13 patients respectively. There were no significant differences in distribution of fibrosis stage and inflammation grade between treated and untreated patient groups. LS with MRE demonstrated stronger correlation with liver fibrosis stage in comparison to laboratory markers for chronic liver disease (r = 0.88 vs -0.48-0.70). A trend of decreased mean LS in treated patients compared to untreated patients was observed (3.7 kPa vs 3.84 kPa) but was not statistically significant. MRE had an accuracy/ sensitivity/specificity/positive predictive value/negative predictive value of 0.97/90%/100%/100%/90% and 0.98/92.3%/96%/92.3%/96% for detection of advanced fibrosis and cirrhosis, respectively. The performance of MRE was significantly better than laboratory tests for detection of advanced fibrosis (0.97 vs 0.53-0.80, p < 0.01), and cirrhosis (0.98 vs 0.58-0.80, p < 0.01) and better than conventional MRI for diagnosis of cirrhosis (0.98 vs 0.78, p = 0.002). CONCLUSION MRE is a promising modality for detection of advanced fibrosis and cirrhosis in patients with AIH with superior diagnostic accuracy compared to laboratory assessment and MRI.

AB - AIM To assess the value of magnetic resonance elastography (MRE) in detecting advanced fibrosis/cirrhosis in autoimmune hepatitis (AIH). METHODS In this retrospective study, 36 patients (19 treated and 17 untreated) with histologically confirmed AIH and liver biopsy performed within 3 mo of MRE were identified at a tertiary care referral center. Liver stiffness (LS) with MRE was calculated by a radiologist, and inflammation grade and fibrosis stage in liver biopsy was assessed by a pathologist in a blinded fashion. Two radiologists evaluated morphological features of cirrhosis on conventional magnetic resonance imaging (MRI). Accuracy of MRE was compared to laboratory markers and MRI for detection of advanced fibrosis/cirrhosis. RESULTS Liver fibrosis stages of 0, 1, 2, 3 and 4 were present in 4, 6, 7, 6 and 13 patients respectively. There were no significant differences in distribution of fibrosis stage and inflammation grade between treated and untreated patient groups. LS with MRE demonstrated stronger correlation with liver fibrosis stage in comparison to laboratory markers for chronic liver disease (r = 0.88 vs -0.48-0.70). A trend of decreased mean LS in treated patients compared to untreated patients was observed (3.7 kPa vs 3.84 kPa) but was not statistically significant. MRE had an accuracy/ sensitivity/specificity/positive predictive value/negative predictive value of 0.97/90%/100%/100%/90% and 0.98/92.3%/96%/92.3%/96% for detection of advanced fibrosis and cirrhosis, respectively. The performance of MRE was significantly better than laboratory tests for detection of advanced fibrosis (0.97 vs 0.53-0.80, p < 0.01), and cirrhosis (0.98 vs 0.58-0.80, p < 0.01) and better than conventional MRI for diagnosis of cirrhosis (0.98 vs 0.78, p = 0.002). CONCLUSION MRE is a promising modality for detection of advanced fibrosis and cirrhosis in patients with AIH with superior diagnostic accuracy compared to laboratory assessment and MRI.

KW - Advanced fibrosis

KW - Autoimmune hepatitis

KW - Cirrhosis

KW - Liver stiffness

KW - Magnetic resonance elastography

UR - http://www.scopus.com/inward/record.url?scp=85011598882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011598882&partnerID=8YFLogxK

U2 - 10.3748/wjg.v23.i5.859

DO - 10.3748/wjg.v23.i5.859

M3 - Article

VL - 23

SP - 859

EP - 868

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 5

ER -